82_FR_21900 82 FR 21811 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

82 FR 21811 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting

DEPARTMENT OF DEFENSE
Office of the Secretary

Federal Register Volume 82, Issue 89 (May 10, 2017)

Page Range21811-21811
FR Document2017-09450

The Department of Defense (DoD) is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place.

Federal Register, Volume 82 Issue 89 (Wednesday, May 10, 2017) 
[Federal Register Volume 82, Number 89 (Wednesday, May 10, 2017)]
[Notices]
[Page 21811]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09450]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Assistant Secretary of Defense (Health Affairs), Department of 
Defense.

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense (DoD) is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel will take place.

DATES: Open to the public Thursday, June 22, 2017 from 9:00 a.m. to 
12:00 p.m.

ADDRESSES: The address of the open meeting is Naval Heritage Center 
Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Edward Norton, 703-681-2890 (Voice), 
703-681-1940 (Facsimile), [email protected] 
(Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls 
Church, VA 22042-5101. Web site: http://www.health.mil/About-MHS/Other-MHS-Organizations/Beneficiary-Advisory-Panel. The most up-to-date 
changes to the meeting agenda can be found on the Web site.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 
U.S.C., Appendix, as amended), the Government in the Sunshine Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
    Purpose of the Meeting: The Department of Defense is publishing 
this notice to announce a Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as 
the Panel).
    Agenda:
    1. Sign-In.
    2. Welcome and Opening Remarks.
    3. Public Citizen Comments.
    4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item).
    a. Ophthalmic-1 Agents.
    b. Pulmonary Miscellaneous.
    5. Newly Approved Drugs Review.
    6. Pertinent Utilization Management Issues.
    7. Panel Discussions and Vote.
    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and 
the availability of space, this meeting is open to the public. Seating 
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
    Written Statements: Pursuant to 41 CFR 102-3.140, the public or 
interested organizations may submit written statements to the 
membership of the Panel at any time or in response to the stated agenda 
of a planned meeting. Written statements should be submitted to the 
Panel's Designated Federal Officer (DFO). The DFO's contact information 
can be obtained from the General Services Administration's Federal 
Advisory Committee Act Database at http://facadatabase.gov/. Written 
statements that do not pertain to the scheduled meeting of the Panel 
may be submitted at any time. However, if individual comments pertain 
to a specific topic being discussed at a planned meeting, then these 
statements must be submitted no later than 5 business days prior to the 
meeting in question. The DFO will review all submitted written 
statements and provide copies to all the committee members.
    Public Comments: In addition to written statements, the Panel will 
set aside 1 hour for individuals or interested groups to address the 
Panel. To ensure consideration of their comments, individuals and 
interested groups should submit written statements as outlined in this 
notice; but if they still want to address the Panel, then they will be 
afforded the opportunity to register to address the Panel. The Panel's 
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for 
registration on a first-come, first-serve basis. Those wishing to 
address the Panel will be given no more than 5 minutes to present their 
comments, and at the end of the 1-hour time period, no further public 
comments will be accepted. Anyone who signs-up to address the Panel, 
but is unable to do so due to the time limitation, may submit their 
comments in writing; however, they must understand that their written 
comments may not be reviewed prior to the Panel's deliberation. To 
ensure timeliness of comments for the official record, the Panel 
encourages that individuals and interested groups consider submitting 
written statements instead of addressing the Panel.

    Dated: May 5, 2017.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2017-09450 Filed 5-9-17; 8:45 am]
BILLING CODE 5001-06-P

Federal Register / Vol. 82, No. 89 / Wednesday, May 10, 2017 / Notices 21811 Note: The yarn size designations describe Purpose of the Meeting: The address the Panel will be given no more a range of yarn specifications for yarn before Department of Defense is publishing than 5 minutes to present their knitting, dyeing and finishing of the fabric. this notice to announce a Federal comments, and at the end of the 1-hour They are intended as specifications to be Advisory Committee meeting of the time period, no further public followed by the mill in sourcing yarn used to produce the fabric. Dyeing, finishing and Uniform Formulary Beneficiary comments will be accepted. Anyone knitting can alter the characteristic of the Advisory Panel (hereafter referred to as who signs-up to address the Panel, but yarn as it appears in the finished fabric. This the Panel). is unable to do so due to the time specification therefore includes yarn sizes Agenda: limitation, may submit their comments provided that the variation occurs after 1. Sign-In. in writing; however, they must processing of the greige yarn and production 2. Welcome and Opening Remarks. understand that their written comments of the fabric. The specifications for the fabric 3. Public Citizen Comments. may not be reviewed prior to the Panel’s apply to the fabric itself prior to cutting and 4. Scheduled Therapeutic Class deliberation. To ensure timeliness of sewing of the finished garment. Such Reviews (Comments will follow each comments for the official record, the processing may alter the measurements. agenda item). Panel encourages that individuals and a. Ophthalmic-1 Agents. interested groups consider submitting Terry Labat, b. Pulmonary Miscellaneous. written statements instead of addressing Acting Chairman, Committee for the 5. Newly Approved Drugs Review. Implementation of Textile Agreements. 6. Pertinent Utilization Management the Panel. [FR Doc. 2017–09430 Filed 5–9–17; 8:45 am] Issues. Dated: May 5, 2017. BILLING CODE 3510–DR–P 7. Panel Discussions and Vote. Aaron Siegel, Meeting Accessibility: Pursuant to 5 Alternate OSD Federal Register Liaison U.S.C. 552b, as amended, and 41 Code Officer, Department of Defense. of Federal Regulations (CFR) 102–3.140 [FR Doc. 2017–09450 Filed 5–9–17; 8:45 am] DEPARTMENT OF DEFENSE through 102–3.165, and the availability BILLING CODE 5001–06–P of space, this meeting is open to the Office of the Secretary public. Seating is limited and will be Uniform Formulary Beneficiary provided only to the first 220 people ENVIRONMENTAL PROTECTION Advisory Panel; Notice of Federal signing-in. All persons must sign-in AGENCY Advisory Committee Meeting legibly. Written Statements: Pursuant to 41 [EPA–HQ–OAR–2011–0742; FRL–9959–69– AGENCY: Assistant Secretary of Defense CFR 102–3.140, the public or interested OEI] (Health Affairs), Department of Defense. organizations may submit written Information Collection Request ACTION: Notice of Federal Advisory statements to the membership of the Submitted to OMB for Review and Committee meeting. Panel at any time or in response to the Approval; Comment Request; Air stated agenda of a planned meeting. Pollution Regulations for Outer SUMMARY: The Department of Defense Written statements should be submitted Continental Shelf (OCS) Activities (DoD) is publishing this notice to to the Panel’s Designated Federal Officer announce that the following Federal (DFO). The DFO’s contact information AGENCY: Environmental Protection Advisory Committee meeting of the can be obtained from the General Agency (EPA). Uniform Formulary Beneficiary Services Administration’s Federal ACTION: Notice. Advisory Panel will take place. Advisory Committee Act Database at DATES: Open to the public Thursday, http://facadatabase.gov/. Written SUMMARY: The Environmental Protection June 22, 2017 from 9:00 a.m. to 12:00 statements that do not pertain to the Agency (EPA) has submitted an p.m. scheduled meeting of the Panel may be information collection request (ICR), submitted at any time. However, if ‘‘Air Pollution Regulations for Outer ADDRESSES: The address of the open Continental Shelf (OCS) Activities’’ to individual comments pertain to a meeting is Naval Heritage Center the Office of Management and Budget specific topic being discussed at a Theater, 701 Pennsylvania Avenue NW., (OMB) for review and approval in planned meeting, then these statements Washington, DC 20004. accordance with the Paperwork must be submitted no later than 5 FOR FURTHER INFORMATION CONTACT: business days prior to the meeting in Reduction Act. This is a proposed Edward Norton, 703–681–2890 (Voice), question. The DFO will review all extension of the ICR. Public comments 703–681–1940 (Facsimile), submitted written statements and were previously requested via the dha.ncr.health-it.mbx.baprequests@ provide copies to all the committee Federal Register on May 29, 2015, mail.mil (Email). Mailing address is members. during a 60-day comment period. This 7700 Arlington Boulevard, Suite 5101, Public Comments: In addition to notice allows for an additional 30 days Falls Church, VA 22042–5101. Web site: written statements, the Panel will set for public comments. A fuller http://www.health.mil/About-MHS/ aside 1 hour for individuals or description of the ICR is given below, Other-MHS-Organizations/Beneficiary- interested groups to address the Panel. including its estimated burden and cost Advisory-Panel. The most up-to-date To ensure consideration of their to the public. An agency may not changes to the meeting agenda can be comments, individuals and interested conduct or sponsor and a person is not found on the Web site. groups should submit written required to respond to a collection of SUPPLEMENTARY INFORMATION: This statements as outlined in this notice; but information unless it displays a jstallworth on DSK7TPTVN1PROD with NOTICES meeting is being held under the if they still want to address the Panel, currently valid OMB control number. provisions of the Federal Advisory then they will be afforded the DATES: Additional comments may be Committee Act (FACA) of 1972 (5 opportunity to register to address the submitted on or before June 9, 2017. U.S.C., Appendix, as amended), the Panel. The Panel’s DFO will have a ADDRESSES: Submit your comments, Government in the Sunshine Act of ‘‘Sign-Up Roster’’ available at the Panel referencing Docket ID No. EPA–HQ– 1976 (5 U.S.C. 552b, as amended), and meeting for registration on a first-come, OAR–2011–0724, to (1) the EPA online 41 CFR 102–3.140 and 102–3.150. first-serve basis. Those wishing to using http://www.regulations.gov (our VerDate Sep<11>2014 15:21 May 09, 2017 Jkt 241001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\10MYN1.SGM 10MYN1


Document Created: 2017-05-10 00:01:07
Document Modified: 2017-05-10 00:01:07
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of Federal Advisory Committee meeting.
DatesOpen to the public Thursday, June 22, 2017 from 9:00 a.m. to 12:00 p.m.
ContactEdward Norton, 703-681-2890 (Voice), 703-681-1940 (Facsimile), [email protected]
FR Citation82 FR 21811 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR